Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples